DocliMed

Systematic review, simplified

Literature search review, reimagined

From PICO query to data extraction — DocliMed gives clinical research teams one focused workspace for every stage of systematic review.

Built for

MedTechPharmaClinical Research TeamsHTA Organizations

Search · PubMed

4 databases selected

PubMed query · generated from PICO

1,284 results · 2.1s
Title/AbstractMeSH Terms2015–2026Humans

Searches across

PubMedEurope PMCCochrane LibraryGoogle ScholarSemantic ScholarFDA MAUDEMHRABfArMHealth CanadaTGASwissmedic
01Why DocliMed

How DocliMed will help you

DocliMed leverages cutting-edge AI to seamlessly automate clinical, regulatory, and quality operations — so your team can focus on what matters most.

Built for MedTech & Pharma compliance

Comprehensive Device Support

Effortlessly handle your entire product portfolio, regardless of device risk classification.

Unlimited Portfolio Growth

Designed for any scale — whether you are an emerging SME or a multinational enterprise managing thousands of Technical Files.

Audit-Ready Global Compliance

Navigate complex international landscapes with built-in compliance for EU MDR, IVDR, FDA and global standards.

01Fast

Smart-ranked results

1,284 in 2.1s

Everolimus-eluting vs bare-metal stents: 5-year outcomes

PubMed

0.94

Stent thrombosis in diabetic cohorts: meta-analysis

Cochrane

0.91

Real-world registry of DES in elderly patients

Europe PMC

0.87
02How it works

Four steps from research question to evidence synthesis

Each stage hands off cleanly to the next. Your team always knows what comes after search, screening, or extraction.

  1. 01

    Build PICO Query

    Define population, intervention, comparison, and outcome with MeSH terms, synonyms, and Boolean logic.

    PICO Search Builder

    Preview: 1,284 results

    PPopulation
    coronary artery diseaseadults
    IIntervention
    drug-eluting stent[MeSH]
    CComparison
    bare-metal stent
    OOutcome
    MACEtarget lesion revascularization

    Search · PubMed

    4 databases selected

    PubMed query · generated from PICO

    1,284 results · 2.1s
    Title/AbstractMeSH Terms2015–2026Humans
  2. 02

    Multi-Database Search

    Search across PubMed, Europe PMC, Cochrane, and Google Scholar — millions of biomedical articles from one interface.

    One search · every source

    sources → DocliMed → outputs

    PubMedEurope PMCCochraneGoogle ScholarFDA MAUDEMHRADocliMeddedupe · rank · screenRanked resultsPRISMA flowDOCX report
  3. 03

    Screen Articles

    Review abstracts with include/exclude decisions, track inter-reviewer agreement, and resolve conflicts.

    Screening · article #1187

    2 independent reviewers

    Long-term outcomes of DES vs BMS in diabetic patients

    PubMed · 2024 · Level 1 screening

    AM

    A. Meyer · Reviewer 1

    Include
    LK

    L. Kaur · Reviewer 2

    Exclude
    SB

    S. Bianchi · Adjudicator

    Include
    Conflict flagged → adjudicator Resolved · Include · logged 09:41:12
  4. 04

    Extract Data

    Capture study design, outcomes, risk of bias, and quality notes in structured, repeatable fields.

    PubMed · 2024 · Full text

    Everolimus-eluting versus bare-metal stents in patients with coronary artery disease

    In this randomised, controlled trial, 1,046 patients with stable coronary artery disease were assigned to an everolimus-eluting or a bare-metal stent.

    The primary endpoint was major adverse cardiac events at 12 months. Allocation was concealed and outcome assessors were blinded; the authors report a low risk of bias across domains.

    Extraction

    0 / 4 fields

    Study designRandomised controlled trial
    Sample sizen = 1,046
    Primary outcomeMACE at 12 months
    Risk of biasLow — RoB 2
03Platform

Everything your review team needs

Purpose-built tools for each stage of systematic review, designed to reduce friction and keep your evidence pipeline moving.

PICO Search Builder

Build structured queries with MeSH terms, synonyms, and per-row field tags. Preview the full PubMed query before executing.

PICO Search Builder

Preview: 1,284 results

PPopulation
coronary artery diseaseadults
IIntervention
drug-eluting stent[MeSH]
CComparison
bare-metal stent
OOutcome
MACEtarget lesion revascularization

Evidence Screening

Include or exclude articles with a structured review flow. Track reviewer progress and maintain complete audit trails.

Screening · Level 1

142 / 238 reviewed

Long-term outcomes of DES vs BMS in diabetic patients

PubMed · 2024

Include

Registry analysis of stent thrombosis, 5-year follow-up

Europe PMC · 2023

Include

Animal model of neointimal hyperplasia after stenting

PubMed · 2021

Exclude

Data Extraction

Capture study design, primary outcomes, risk of bias, and quality notes in a consistent, structured format.

Extraction · MEDDEV template

4 / 12 fields

Study designRandomised controlled trial
Sample sizen = 1,046
Primary outcomeMACE at 12 months
Risk of biasLow — RoB 2

Team Collaboration

Shared workspaces with role-based access, invitation flows, and visibility into team progress across every stage.

Workspace team

3 members · 2 conflicts open

AM

A. Meyer · Reviewer 1

72%
LK

L. Kaur · Reviewer 2

64%
SB

S. Bianchi · Adjudicator

31%
04What you get

From 1,284 records to a defensible report

Every record is counted, every exclusion carries a reason, and the result exports as a DOCX report a Notified Body can follow line by line.

Identification

0

records from 5 databases and 7 vigilance sources

Screening

0

182 duplicates removed · 864 excluded on title/abstract

Eligibility

0

full texts assessed · 171 excluded with a recorded reason

Included

0

studies in the qualitative synthesis

Literature Search Report · v1.3

Coronary stents — Clinical Evaluation, MDR Annex XIV

  1. 1.Search strategy and sources
  2. 2.PRISMA flow and exclusion reasons
  3. 3.Included studies (67) and appraisal
  4. 4.Vigilance summary — 7 sources
StudyDesignRoBMeyer 2024RCTLowKaur 2023RegistrySome
Export .docx

0

Literature databases

0

Vigilance sources

0

Independent reviewers per study

DOCX

Regulatory-ready reports

Powerful Search, Real-time Updates and Fully Organized

All the MedTech and Pharma Intelligence You Need

01

Fundamentally, DocliMed is a data platform — powered by advanced software products and solutions built to make sense of complexity.

02

Every day, DocliMed collects and organizes vast amounts of information, much of it highly complex in format and structure. Behind the scenes, data science (coding, mathematical models and AI), work with algorithmic precision to transform raw data into information at your fingertips.

03

The result: powerful automation combined with complete flexibility. Customize your workflows, shape your data, and perform your tasks without restrictions — just you, the data, and the insights you need.

06Regulatory and Clinical Strategy

Five principles that shape every pathway

How regulatory and clinical pathways are planned, submitted, and maintained across the product lifecycle.

Strategic

Regulatory pathways are aligned to business and clinical objectives from the outset — not bolted on after development decisions are made.

Precise

Submissions are built on data-driven evidence and exact documentation, leaving no ambiguity for reviewers to resolve.

Compliant

Every action is measured against current global standards, keeping the dossier defensible during audits and inspections.

Agile

The strategy adapts quickly as regulations, guidance, and market requirements shift, without losing course.

Transparent

Communication with Notified Bodies and Health Authorities is clear, timely, and fully documented at every stage of review.

These principles guide our Strategic Consulting and Medical Writing services — audit-ready documentation for MDR, IVDR, and FDA submissions.

Explore services

Ready to streamline your evidence review?

Join research teams using DocliMed to move from question to evidence faster, with less friction.

07FAQ

Common questions from research teams

Can't find what you're looking for? Reach out to our support team.

DocliMed is designed for medical research teams, systematic reviewers, clinical evidence groups, and health technology assessment organizations that need a structured, collaborative literature review workflow.

The builder lets you define structured search components (Population, Intervention, Comparison, Outcome) with support for MeSH terms, synonyms, per-row field tags (Title/Abstract, MeSH Terms, All Fields, etc.), and Boolean operators. It generates a valid PubMed query string you can preview and refine.

Yes. Projects support shared workspaces with invitation flows and role-based access. Team members screen articles independently, and the platform tracks progress and flags conflicts for resolution.

DocliMed searches across PubMed, Europe PMC, Cochrane Library, and Google Scholar — giving you access to millions of biomedical articles from a single interface.

Yes. DocliMed supports Clinical Evaluation (MDR) and Clinical Performance (IVDR) work — including systematic literature search across major scientific and vigilance databases with transparent methodologies and robust appraisal according to MDR Annex XIV, IVDR requirements, MDCGs and MEDDEV guidance.

Yes. Our specialized medical writing team helps medical device and IVD manufacturers create clear, audit-ready technical and clinical documentation for MDR, IVDR, and FDA submissions — from development phase through post-market lifecycle management.

All data is encrypted in transit and at rest. Projects are isolated by workspace, and access is controlled through role-based permissions with full audit logging.